Skip to main content

Epsolay FDA Approval History

Last updated by Judith Stewart, BPharm on April 27, 2022.

FDA Approved: Yes (First approved April 22, 2022)
Brand name: Epsolay
Generic name: benzoyl peroxide
Dosage form: Cream
Company: Sol-Gel Technologies, Ltd.
Treatment for: Rosacea

Epsolay (benzoyl peroxide) is a topical oxidizing agent for the treatment of inflammatory lesions of rosacea in adults.

Development timeline for Epsolay

Apr 25, 2022Approval FDA Approves Epsolay (benzoyl peroxide) Cream for the Treatment of Rosacea
Apr 27, 2021Sol-Gel Technologies Provides Update on FDA Review of Epsolay
Sep 10, 2020Sol-Gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Epsolay (benzoyl peroxide) for the Treatment of Inflammatory Lesions of Rosacea

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.